amfAR, The Foundation for AIDS Research
The five-year $14.5 million award will support efforts to integrate clinical care and research and target vulnerable communities.
amfAR CEO Kevin Robert Frost looks to the future with a measure of optimism and a lot of gratitude.
amfAR returned to the South of France for its flagship benefit gala featuring Sharon Stone, Alicia Keys, Spike Lee, and much, much more.
New amfAR infographics show how transgender populations are not adequately represented in national HIV strategic plans.
New Krim Fellows will harness powerful technologies in support of HIV vaccine and latency studies.
Grants awarded through amfAR Fund to Fight COVID-19 will investigate “long-haulers” and effect of coronavirus on HIV reservoir.
The rapid development of COVID vaccines would not have been possible without innovative foundations developed through HIV vaccine research.
CDC reports show “hopeful signs of progress,” including 8% decline in new HIV infections from 2015 to 2019.
The site is an important new source of information on COVID-19 vaccines and therapeutics.
PRNEWS panel declared amfAR’s Epic Voices to be inspiring, innovative, and deserving of industry-wide recognition for its impact on the global community.
Meet Jonathan Cohen, Director of the Global Public Health Program at Open Society Foundations. Jonathan spoke to amfAR about an opinion piece he wrote for STAT News, where he discussed his decision to publicly disclose his HIV status upon getting a Covid-19 vaccination.
We are constantly gathering new information to keep you up to date on the intersection between HIV and COVID-19. The hard-won lessons of HIV research are informing the race to find effective treatments and a vaccine for COVID-19.
Benefit amfAR While You Shop on AmazonIf you shop at AmazonSmile, you can benefit amfAR with every purchase—at no cost to you!
© 2021 amfAR All Rights Reserved || amfAR's mission is to end the global AIDS epidemic through innovative research